Valeos announces collaboration with technology
powerhouse, Oracle, to unite stakeholders in the organ transplant
ecosystem through data, technology, and collaboration to drive
better patient outcomes.
VEGAS, Sept. 18, 2023 /PRNewswire/ -- Valeos, a
leading nonprofit organization designed to radically improve organ
transplant outcomes, is working with Oracle Health, a global leader
in healthcare technology solutions, to address the challenges of
the current organ transplant system through data and technology.
With more than 100,000 Americans awaiting transplant, and many
others who never get listed, the U.S. organ transplant system is in
desperate need of modernization — and Valeos is accelerating that
transformation through connected data.
"During my emergency heart transplant journey in 2021, our
family experienced firsthand that the transplant system needs vast
improvements to better serve patients and donors," said
Tristan Mace, Executive Chairman and
Co-Founder at Valeos, a serial tech entrepreneur turned venture
capitalist. "Today, transplant data is siloed at hospitals,
transplant centers, organ procurement organizations, logistic
companies, and vendors, making collaboration difficult to provide
patients with greater access to high-quality transplants, shorter
waitlist times, longer life expectancy, and higher quality of life.
Valeos is going to solve this problem."
Oracle has been a design partner for Valeos, volunteering its
deep expertise in healthcare and data management as the company
looks to disrupt the transplant industry.
To celebrate this collaboration and progress towards healthcare
modernization, Tristan and his wife Jordan
Mace, Co-Chair and Co-Founder at Valeos, will be keynote
speakers at the Oracle Health Conference in Las Vegas today. At the conference, Tristan
and Jordan will share their personal journey with transplant to
highlight the need for connected data in healthcare and the
Valeos' collaboration with Oracle Health marks a significant
milestone to uniting transplant stakeholders through aggregated and
longitudinal patient data. Oracle is providing Valeos access to
industry-leading expertise in electronic health records (EHRs),
complex integrations, cloud infrastructure, security, and
During the keynote address, Oracle will present a powerful video
highlighting Tristan's and his family's journey as a transplant
recipient and the work Valeos is doing to solve transplant's
"The drive Tristan and Jordan have to build Valeos and reimagine
the transplant patient experience is extraordinary," said
Stephanie Trunzo, senior vice
president of Oracle Health. "Oracle is proud to volunteer our
expertise as a design partner to Valeos to help bring their vision
to life and hopefully make an impact on the outcomes of patients in
need of transplants."
For more information, visit https://valeos.org/.
Visit https://www.oracle.com/oracle-health-conference/ to
learn more and register.
Valeos Transplant Society is a
patient-founded, patient-centric 501(c)(3) tax-exempt nonprofit
based in Washington, D.C. designed to improve transplant outcomes
through data, technology, and collaboration.
With more than 100,000 Americans awaiting transplant, the U.S.
organ transplant system is in desperate need of modernization.
Valeos connects the transplant ecosystem through longitudinal data
to unlock new learnings and innovation for greater access to
high-quality transplants, shorter waitlist times, and improved
post-transplant life expectancy and quality of life.
Oracle offers integrated suites of
applications plus secure, autonomous infrastructure in the Oracle
Cloud. For more information about Oracle (NYSE: ORCL), please visit
us at www.oracle.com.
Oracle, Java, MySQL and NetSuite are
registered trademarks of Oracle Corporation. NetSuite was the first
cloud company--ushering in the new era of cloud computing.
View original content to download